Literature DB >> 23391162

Structure-relaxivity relationships of serum albumin targeted MRI probes based on a single amino acid Gd complex.

Eszter Boros1, Peter Caravan.   

Abstract

The Gd(III) complex of DO3A-N-α-aminopropionate, Gd(DOTAla), was used to generate a small library of putative MRI probes targeted to human serum albumin (HSA). Ten compounds were synthesized via multistep organic synthesis, and the corresponding Gd complexes were investigated for their affinity to HSA, lipophilicity, and relaxivity in the absence and presence of HSA. Negative charge and moderate lipophilicity correlate with increased HSA affinity and relaxivity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23391162      PMCID: PMC3656968          DOI: 10.1021/jm4000177

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  19 in total

1.  Enzyme-Activated Gd(3+) Magnetic Resonance Imaging Contrast Agents with a Prominent Receptor-Induced Magnetization Enhancement We thank Dr. Shrikumar Nair for helpful discussions.

Authors:  Alexander L. Nivorozhkin; Andrew F. Kolodziej; Peter Caravan; Matthew T. Greenfield; Randall B. Lauffer; Thomas J. McMurry
Journal:  Angew Chem Int Ed Engl       Date:  2001-08-03       Impact factor: 15.336

2.  Synthesis and physicochemical characterization of Gd-C4-thyroxin-DTPA, a potential MRI contrast agent. Evaluation of its affinity for human serum albumin by proton relaxometry, NMR diffusometry, and electrospray mass spectrometry.

Authors:  C Henoumont; L Vander Elst; S Laurent; R N Muller
Journal:  J Phys Chem B       Date:  2010-03-18       Impact factor: 2.991

3.  Synthesis and physicochemical characterization of two gadolinium(III) TTDA-like complexes and their interaction with human serum albumin.

Authors:  Ming-Hung Ou; Chien-Hung Tu; Su-Ching Tsai; Wei-Thung Lee; Gin-Chung Liu; Yun-Ming Wang
Journal:  Inorg Chem       Date:  2006-01-09       Impact factor: 5.165

4.  Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths.

Authors:  Martin Rohrer; Hans Bauer; Jan Mintorovitch; Martin Requardt; Hanns-Joachim Weinmann
Journal:  Invest Radiol       Date:  2005-11       Impact factor: 6.016

Review 5.  Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.

Authors:  Peter Caravan
Journal:  Chem Soc Rev       Date:  2006-05-03       Impact factor: 54.564

6.  Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.

Authors:  Peter Caravan
Journal:  Acc Chem Res       Date:  2009-07-21       Impact factor: 22.384

7.  The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates.

Authors:  Peter Caravan; Normand J Cloutier; Matthew T Greenfield; Sarah A McDermid; Stephen U Dunham; Jeff W M Bulte; John C Amedio; Richard J Looby; Ronald M Supkowski; William DeW Horrocks; Thomas J McMurry; Randall B Lauffer
Journal:  J Am Chem Soc       Date:  2002-03-27       Impact factor: 15.419

8.  Structure - relaxivity relationships among targeted MR contrast agents.

Authors:  Peter Caravan; Zhaoda Zhang
Journal:  Eur J Inorg Chem       Date:  2012-04       Impact factor: 2.524

9.  Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents.

Authors:  Peter Caravan; Christian T Farrar; Luca Frullano; Ritika Uppal
Journal:  Contrast Media Mol Imaging       Date:  2009 Mar-Apr       Impact factor: 3.161

10.  The effect of a phosphodiester linking group on albumin binding, blood half-life, and relaxivity of intravascular diethylenetriaminepentaacetato aquo gadolinium(III) MRI contrast agents.

Authors:  Thomas J McMurry; David J Parmelee; Hironao Sajiki; Daniel M Scott; Hillori S Ouellet; Richard C Walovitch; Zoltán Tyeklár; Stéphane Dumas; Paul Bernard; Samuel Nadler; Katarina Midelfort; Matthew Greenfield; Jeffrey Troughton; Randall B Lauffer
Journal:  J Med Chem       Date:  2002-08-01       Impact factor: 7.446

View more
  9 in total

1.  Probing the structure-relaxivity relationship of bis-hydrated Gd(DOTAla) derivatives.

Authors:  Eszter Boros; Peter Caravan
Journal:  Inorg Chem       Date:  2015-02-18       Impact factor: 5.165

2.  Intramolecular Hydrogen Bonding Restricts Gd-Aqua-Ligand Dynamics.

Authors:  Eszter Boros; Raja Srinivas; Hee-Kyung Kim; Arnold M Raitsimring; Andrei V Astashkin; Oleg G Poluektov; Jens Niklas; Andrew D Horning; Bruce Tidor; Peter Caravan
Journal:  Angew Chem Int Ed Engl       Date:  2017-04-11       Impact factor: 15.336

Review 3.  Lipophilic Conjugates of Drugs: A Tool to Improve Drug Pharmacokinetic and Therapeutic Profiles.

Authors:  Sifei Han; Lianghe Mei; Tim Quach; Chris Porter; Natalie Trevaskis
Journal:  Pharm Res       Date:  2021-08-31       Impact factor: 4.200

Review 4.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

5.  Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI.

Authors:  Zhuxian Zhou; Xueming Wu; Adam Kresak; Mark Griswold; Zheng-Rong Lu
Journal:  Biomaterials       Date:  2013-07-14       Impact factor: 12.479

6.  B25716/1: a novel albumin-binding Gd-AAZTA MRI contrast agent with improved properties in tumor imaging.

Authors:  E Gianolio; C Cabella; S Colombo Serra; G Valbusa; F Arena; A Maiocchi; L Miragoli; F Tedoldi; F Uggeri; M Visigalli; P Bardini; S Aime
Journal:  J Biol Inorg Chem       Date:  2014-02-08       Impact factor: 3.358

7.  Gd(DOTAlaP): exploring the boundaries of fast water exchange in gadolinium-based magnetic resonance imaging contrast agents.

Authors:  Eszter Boros; Shima Karimi; Nathaniel Kenton; Lothar Helm; Peter Caravan
Journal:  Inorg Chem       Date:  2014-06-12       Impact factor: 5.165

8.  Impact of multiple negative charges on blood clearance and biodistribution characteristics of 99mTc-labeled dimeric cyclic RGD peptides.

Authors:  Yong Yang; Shundong Ji; Shuang Liu
Journal:  Bioconjug Chem       Date:  2014-08-21       Impact factor: 4.774

9.  Lanthanide(III) complexes of rhodamine-DO3A conjugates as agents for dual-modal imaging.

Authors:  Charlotte Rivas; Graeme J Stasiuk; Juan Gallo; Florencia Minuzzi; Guy A Rutter; Nicholas J Long
Journal:  Inorg Chem       Date:  2013-12-04       Impact factor: 5.165

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.